The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.

BD said all configurations feature high-throughput automation and software designed for large dataset management and ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

The Francis Crick Institute’s flow cytometry core has shown at ELRIG 2025 how a heterogeneous fleet of spectral, mass and ...

Study links anxiety to 74% fewer natural killer cells—immune defenders against cancer and infections. Insomnia intensifies ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

MRD negativity post-chemotherapy strongly predicts improved overall survival in AML, with a significant reduction in mortality risk. The study suggests MRD could serve as an earlier surrogate endpoint ...

Early treatment correlates with better immune fitness, marked by higher CD4-positive naive T cells and a favorable tumor microenvironment. Cilta-cel therapy shows improved outcomes in earlier ...

Study met its secondary endpoints and demonstrated improvement in biomarkers of collagen turnover, suggesting a resolution of fibrosis and repair of the alveolar basement membrane GRI-0621 ...

Analysis of the neutrophil proteome, i.e. the majority of all expressed proteins, can provide valuable insights into the functional dynamics of neutrophils under disease conditions. However, although ...